Bengaluru: The ‘warm’ vaccine formulation developed by scientists at IISC along with the biotech company MyNVAX is effective against all variants of the current SARS-COV-2 concern, independent evaluation of the formulation carried out by CSIRO, Australia has shown.
CSIRO found that the ‘warm’ vaccine helped produce antibodies that neutralized all the current variants of the Coronavirus novel.
This finding was published on Thursday in the Journal of the ACS Peer-Review Infectious Disease.
This will open the way for the clinical development of vaccines, which lead to human trials.
This study was led by Prof.
Raghavan Varadarajan from IISC.
Toi first reported about vaccines in November 2020.
The researchers have shown a stable formulation at 37 ° C for a month and at 100 ° C to 90 minutes – sign the tag ‘warm vaccine’.
Covid: ‘warm’ vaccine was found effective against all variants, said report
